HALO Stock Halozyme Therapeutics (HALO, $51.55) soared +28.62% and reached a 3-month high

A.I.dvisor
at Tickeron.com
06/22/24
Loading...
HALO - Halozyme Therapeutics

Loading...

Price: $51.55
Daily change: +$0.69 (+1.36%)
Daily volume: 1.6M
3-month price change: +$11.47 (+28.62%)
Capitalization: $6.6B
Industry: Biotechnology
Halozyme Therapeutics (HALO, $51.55) gained +2 and reached a new high over the last three months. By comparison, the broader Biotechnology Industry returned over the same period of time. A.I.dvisor analyzed 890 stocks in the Biotechnology Industry over the same period of time and found that of them (3) were in an Uptrend while of them (6) showed a Downtrend.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com